LucenceINSIGHT Multi-Cancer Early Screening
What is LucenceINSIGHT multi-cancer early screening?
LucenceINSIGHT is an early detection tool that screens for signs of up to 50 different cancers using a simple blood test. This includes eye cancer, breast cancer, colon cancer, acute myeloid leukaemia (AML), and skin cancer. By harnessing the power of advanced genomics, and artificial intelligence, it can detect cancer at its earliest stages. Additionally, it can also predict the location of these cancer biomarkers through its advanced sequencing analysis, thereby prompting timely intervention and treatment.
How does LucenceINSIGHT multi-cancer early screening work?
Through a simple blood draw, the blood test detects cancer by analysing the DNA particles that are shed by tumours into the bloodstream. Additionally, with the use of advanced genomics technology, a specialised computer is then used to help identify genetic changes linked to cancer. It can also analyse the type, and stage of cancer, which ultimately aids doctors in outlining a more personalised treatment plan, apart from diagnosing, and monitoring cancer earlier, and more accurately.
Benefits of LucenceINSIGHT multi-cancer early screening
Some of the benefits of LucenceINSIGHT multi-cancer early screening are:
- Accuracy: the test offers a sensitivity range of 81 to 99% to reduce false positives, and negatives.
- Comprehensive: the test detects up to 50 types of cancer, including breast, colon, prostate, and lung.
- Early detection: the test detects cancer before symptoms begin to present themselves, thereby improving the treatment outcomes.
- Non-invasive: the test works via a simple blood draw and requires no biopsy or surgical probe.
When is LucenceINSIGHT multi-cancer early screening recommended?
LucenceINSIGHT is often recommended as an additional test on top of existing screening tools, such as an ultrasound for prostate cancer. It is also recommended when patients are presented with risk factors that increase their likelihood of developing cancer;
- Age: the test is recommended for individuals aged 40 years old or older.
- Family history: individuals with a family history of cancer are recommended to undergo the screening test.
- Diet: individuals who consume a high-fat, low-fibre diet are encouraged to undergo the screening test as the diet has been linked with an increased risk of cancer, especially bowel, and prostate cancer.
- Health history: the test is highly recommended for individuals who have had a history of viral infections such as Human papillomavirus (HPV) and Epstein-Barr virus (EBV). Additionally, LucenseINSIGHT is also warranted for individuals with predisposing conditions such as Type II diabetes.
- Lifestyle: individuals who smoke, consume alcohol excessively, or barely engage in physical activity are encouraged to undergo this screening test.
Why is early cancer screening important?
Globally, approximately 19 million new cases are recorded annually, with half of the cases resulting in late-stage deaths. In Singapore, cancer is the number one cause of death, and Singapore’s ageing population further increases the prevalence of cancer. Beyond that, approximately 78% of cancer deaths are from unscreened cancers such as liver, stomach, pancreas, and nasopharyngeal cancer.
Between 2017, and 2021, an average of 46 individuals were diagnosed with cancer, and 16 individuals lost their lives to cancer daily in Singapore. Additionally, 1 in 4 people is at risk of developing cancer in their lifetime due to a multitude of factors, such as genetics, and lifestyle. With such a high prevalence, early detection, and intervention are key to a more positive treatment outcome.
Additionally, early cancer screening can also help to:
- Increasing recovery chances.
- Increasing optimal survival odds (the survival rate is increased by 4 times with early diagnosis).
- Lowering medical costs (the more advanced the cancer is, the higher the medical bills).
- Minimise cancer-related complications.
- Preventing cancer from progressing to advanced stages.
What results can I expect from LucenceINSIGHT multi-cancer early screening?
Depending on the results, your next course of action would entail:
Positive results
- A positive result indicates that cancer biomarkers are present.
- The result will also highlight possible localisation areas, indicating where the abnormalities originate from.
- Our doctor will recommend further diagnostic tests to reach a definitive diagnosis.
Negative results
- A negative result indicates that cancer biomarkers are absent.
- However, the result does not disregard the possibility of cancer.
- Keep in mind that the test screens for 50 types of cancer, and not all types of cancer.
- Our doctor will recommend routine screening as a preventive measure.
How many sessions are typically recommended?
Similar to health screenings, it is recommended to schedule cancer screenings annually, or biannually. However, when it comes to cancer screening, the frequency will depend on your doctor’s discretion as it involves several factors such as type of cancer, stage, family history, and current health conditions.
If you are interested in scheduling an early cancer screening for yourself or your loved ones, then wait no more. Contact us today to book a slot, and speak with our doctors to stay a step ahead of this disease.
Frequently asked questions
How accurate are the results from the LucenceINSIGHT multi-cancer early screening?
The LucenceINSIGHT multi-cancer early screening test offers an accuracy range between 81, and 99%.
How does the LucenceINSIGHT multi-cancer early screening differ from conventional screening tests?
The major difference between the two is that LucenceINSIGHT can detect up to 50 types of cancer from a single blood sample. Meanwhile, conventional screening tests typically target a specific type of cancer.
Are there any risks associated with the LucenceINSIGHT multi-cancer early screening that I should be aware of?
While there are no risks associated with the screening test, it is important to understand that the test is designed to screen for cancer, and not to diagnose it.
How soon will I obtain my results?
It takes approximately 12 to 18 days for you to receive your results. Once our doctors have received your results, our administrative staff will call you to schedule a consultation appointment, where our doctors will analyse, and explain the results to you.